Franklin Resources
MRNS

Franklin Resources’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Franklin Resources’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,713,014
Closed -$8.48M – 3062
2024
Q3 		$8.48M Buy
4,713,014
+1,219,871
+35% +$1.7M ﹤0.01% 1176
2024
Q2 		$4.09M Sell
3,493,143
-110
-0% -$275 ﹤0.01% 1396
2024
Q1 		$31.6M Sell
3,493,253
-340,702
-9% -$3.31M 0.01% 724
2023
Q4 		$41.7M Buy
3,833,955
+49,589
+1% +$372K 0.02% 559
2023
Q3 		$30.5M Buy
3,784,366
+2,467,498
+187% +$20.5M 0.02% 635
2023
Q2 		$14.3M Buy
1,316,868
+291,033
+28% +$2.49M 0.01% 844
2023
Q1 		$7.08M Buy
1,025,835
+588,135
+134% +$3.69M ﹤0.01% 1009
2022
Q4 		$1.74M Hold
437,700
– – ﹤0.01% 1398
2022
Q3 		$2.91M Hold
437,700
– – ﹤0.01% 1232
2022
Q2 		$2.12M Buy
437,700
+80,500
+23% +$490K ﹤0.01% 1335
2022
Q1 		$3.34M Hold
357,200
– – ﹤0.01% 1266
2021
Q4 		$4.24M Hold
357,200
– – ﹤0.01% 1267
2021
Q3 		$4.07M Hold
357,200
– – ﹤0.01% 1248
2021
Q2 		$6.41M Hold
357,200
– – ﹤0.01% 1084
2021
Q1 		$5.53M Hold
357,200
– – ﹤0.01% 1084
2020
Q4 		$4.36M Buy
+357,200
New +$4.98M ﹤0.01% 1127
2019
Q4 		– Sell
-607,630
Closed -$3.74M – 1588
2019
Q3 		$3.74M Hold
607,630
– – ﹤0.01% 1055
2019
Q2 		$10.1M Hold
607,630
– – 0.01% 887
2019
Q1 		$10.2M Buy
607,630
+28,250
+5% +$407K 0.01% 871
2018
Q4 		$6.65M Buy
579,380
+133,334
+30% +$2.7M ﹤0.01% 945
2018
Q3 		$17.8M Sell
446,046
-35,975
-7% -$1.02M 0.01% 808
2018
Q2 		$13.6M Buy
482,021
+65,125
+16% +$1.44M 0.01% 871
2018
Q1 		$6.37M Sell
416,896
-119,950
-22% -$2.86M ﹤0.01% 1001
2017
Q4 		$17.5M Sell
536,846
-8,700
-2% -$234K 0.01% 829
2017
Q3 		$12.8M Hold
545,546
– – 0.01% 892
2017
Q2 		$2.99M Hold
545,546
– – ﹤0.01% 1171
2017
Q1 		$3.86M Hold
545,546
– – ﹤0.01% 1143
2016
Q4 		$2.2M Hold
545,546
– – ﹤0.01% 1215
2016
Q3 		$3.97M Hold
545,546
– – ﹤0.01% 1148
2016
Q2 		$2.77M Hold
545,546
– – ﹤0.01% 1209
2016
Q1 		$11.7M Buy
545,546
+69,975
+15% +$1.48M 0.01% 936
2015
Q4 		$14.5M Buy
475,571
+202,925
+74% +$5.95M 0.01% 920
2015
Q3 		$9.1M Sell
272,646
-52,800
-16% -$2.98M ﹤0.01% 1038
2015
Q2 		$15.1M Buy
325,446
+19,671
+6% +$735K 0.01% 946
2015
Q1 		$11M Sell
305,775
-41,500
-12% -$1.82M 0.01% 1032
2014
Q4 		$14.6M Sell
347,275
-100
-0% -$2.9K 0.01% 974
2014
Q3 		$8.99M Buy
+347,375
New +$10.7M ﹤0.01% 1065

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources's MRNS Position: Q4 2024 in Review

Franklin Resources sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 4,713,014 shares — an estimated $8.48M sold.

Franklin Resources first reported a position in MRNS in Q3 2014 and held it in 37 quarters. The position peaked at $41.7M in Q4 2023. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Franklin Resources reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Franklin Resources sold 4,713,014 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $8.48M.
  • Franklin Resources first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and held it in 37 quarters.
  • Franklin Resources's Marinus Pharmaceuticals, Inc position peaked at $41.7M in Q4 2023.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Franklin Resources's 13F filing for Q4 2024, filed 12 Feb 2025.